SCHEMBL24310302

SCHEMBL24310302

Cc1cccc(Cl)c1Oc1cc(-c2ccccc2)nc(NSc2ccccc2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.37
KDM4E B2RXH2 3/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TDP1 Q9NUW8 3/20 0.35
MAPK1 P28482 1/20 0.35
AGTR1 P30556 2/20 0.34
ALDH1A1 P00352 4/20 0.33
L3MBTL1 Q9Y468 3/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
ADORA1 P30542 3/20 0.33
GAA P10253 1/20 0.32
GPR39 O43194 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310579 0.80 RORC (0.35) BRD4KDM4ELMNACYP1A2CYP2C19
SCHEMBL29567001 0.80 MAPT (0.50) BRD4KDM4ELMNACYP1A2CYP2C19
SCHEMBL24310303 0.80 MAPT (0.50) BRD4KDM4ELMNACYP1A2CYP2C19
SCHEMBL24310314 0.80 RORC (0.35) BRD4KDM4ELMNACYP1A2CYP2C19
SCHEMBL24309752 0.79 MAPK1 (0.57) CYP1A2CYP2C19TDP1MAPK1AGTR1
SCHEMBL24310289 0.76 AGTR1 (0.46) KDM4ELMNANPSR1TDP1MAPK1
SCHEMBL24310009 0.76 GPR39 (0.45) KDM4ELMNACYP1A2CYP2C19NPSR1
SCHEMBL24309309 0.75 KDM4E (0.34) BRD4KDM4ELMNACYP1A2CYP2C19
SCHEMBL24310546 0.74 MAPK1 (0.49) KDM4ECYP1A2CYP2C19TDP1MAPK1
SCHEMBL11289134 0.74 AGTR1 (0.56) CYP1A2CYP2C19NPSR1TDP1AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed